Something to note: oral treatment & if successful:
https://www.google.com.au/amp/s/www.nytimes.com/2021/10/17/health/covid-treatment-access-molnupiravir.amp.html
3% vaccination rate across Africa, quoted in this article. That’s appalling. Oral treatments for COVID-19 should know no boundaries. They don’t need cold-chain nor expense or expertise to hospitals administering IV expensive MABS. Other Drug companies (ie Merck) will allow out-licensing with cheaper cost to Govts/patients for oral antivirals +/- WHO support.
https://www.reuters.com/business/healthcare-pharmaceuticals/aurobindo-pharma-stop-molnupiravir-trial-moderate-covid-19-patients-2021-10-08/
Interesting article above on Molnupiravir trials in India.
GLTAH![]()
- Forums
- ASX - By Stock
- DXB
- DXB Chart
DXB Chart, page-118
-
-
- There are more pages in this discussion • 871 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
57.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $313.3M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15517 | 58.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
55.5¢ | 3000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15517 | 0.580 |
1 | 303 | 0.575 |
11 | 101326 | 0.570 |
3 | 48987 | 0.565 |
9 | 225102 | 0.560 |
Price($) | Vol. | No. |
---|---|---|
0.555 | 3000 | 1 |
0.560 | 49307 | 2 |
0.565 | 2320 | 2 |
0.570 | 29256 | 4 |
0.575 | 29584 | 2 |
Last trade - 09.48am 19/06/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
Day chart unavailable
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online